Geneva, Dec. 23 -- International Clinical Trials Registry received information related to the study (ACTRN12625001394437) titled 'A Feasibility Study of the ULTRA Embolic Device' on Dec. 12.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Type of endpoint: Safety/efficacy
Primary Sponsor: Libble Ginster
Condition:
Embolisation of Vasular Tumours
Embolisation of blood vessels to occlude blood flow to control bleeding / haemorrhaging in the peripheral vasculature
Embolisation of Vasular Tumours
Embolisation of blood vessels to occlude blood flow to control bleeding / haemorrhaging in the peripheral vasculature
Cancer - Kidney
Cancer - Liver
Cancer - Other cancer types
Cardiovascular - Dise...